Small Cap Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1889 Sanai Health Industry Group	HK$0.39	14.9%	-74.3%	HK$58.9m	n/a	PE4.2x	n/a	n/a
1228 CANbridge Pharmaceuticals	HK$0.15	23.3%	-79.4%	HK$62.9m	n/a	PE-0.1x	n/a	n/a
1011 China NT Pharma Group	HK$0.25	0%	-50.0%	HK$66.0m	n/a	PS2x	n/a	0%
575 Regent Pacific Group	HK$0.38	0%	-34.2%	HK$85.7m	n/a	PS215.7x	n/a	n/a
8247 Biosino Bio-Technology and Science Incorporation	HK$0.62	-16.2%	-28.7%	HK$89.7m	n/a	PB0.4x	n/a	0%
8158 China Regenerative Medicine International	HK$0.29	-1.7%	-44.3%	HK$89.8m	n/a	PS1.6x	n/a	n/a
858 Extrawell Pharmaceutical Holdings	HK$0.051	6.3%	75.9%	HK$121.9m	n/a	PE0.7x	n/a	n/a
1312 Kontafarma China Holdings	HK$0.03	-3.2%	-14.3%	HK$167.7m	n/a	PB0.2x	n/a	0%
8225 China Health Group	HK$0.19	-5.6%	12.7%	HK$185.1m	n/a	PS7.1x	n/a	n/a
1498 PuraPharm	HK$0.53	-7.0%	-37.6%	HK$209.4m	n/a	PB1.6x	n/a	0%
1643 Modern Chinese Medicine Group	HK$0.35	9.4%	1.4%	HK$210.0m	n/a	PE13.8x	n/a	0%
6628 Transcenta Holding	HK$0.62	1.6%	-82.8%	HK$250.8m	HK$14.07	PS10.6x	E11.0%	n/a
2257 Sirnaomics	HK$2.94	-3.9%	-90.5%	HK$255.2m	HK$72.10	PS30.4x	S50.7%	n/a
8329 Shenzhen Neptunus Interlong Bio-technique	HK$0.16	2.6%	0.6%	HK$268.5m	n/a	PE7.9x	n/a	n/a
6118 Austar Lifesciences	HK$0.54	-5.3%	-72.7%	HK$276.8m	n/a	PB0.3x	n/a	0%
2197 Clover Biopharmaceuticals	HK$0.23	2.2%	-51.3%	HK$297.0m	n/a	PS9.7x	n/a	n/a
897 Wai Yuen Tong Medicine Holdings	HK$0.32	8.5%	-17.9%	HK$360.0m	n/a	PE173.8x	n/a	9.4%
690 Uni-Bio Science Group	HK$0.063	0%	-29.2%	HK$376.2m	n/a	PE3.8x	n/a	n/a
9939 Kintor Pharmaceutical	HK$0.90	1.1%	-30.8%	HK$389.7m	n/a	PB0.9x	n/a	n/a
455 Tianda Pharmaceuticals	HK$0.19	14.5%	-1.0%	HK$406.4m	n/a	PS1.1x	n/a	1.4%
6996 Antengene	HK$0.70	-1.4%	-50.0%	HK$475.6m	HK$1.65	PS8x	E17.0%	n/a
1652 Fusen Pharmaceutical	HK$0.69	0%	-46.5%	HK$510.1m	n/a	PS1.1x	n/a	0%
2126 JW (Cayman) Therapeutics	HK$1.31	4.0%	-34.2%	HK$530.0m	HK$2.40	PS2.9x	E-1.8%	n/a
2511 HighTide Therapeutics	HK$1.15	6.5%	-90.0%	HK$592.0m	n/a	PB1x	n/a	n/a